Insider trades
Kevin Michael Krause, Chief Officer of AN2 Therapeutics ANTX, has filed 0 purchases and 2 sales on the open market. The latest trade was on 24/03/15.
Kevin Michael Krause
Chief Strategy Officer
- Company
- AN2 Therapeutics ANTX
- First filing
- 23/02/17
- Trades
- 12 trades
- Buys / sales
- 0 / 2
- 12-month net buying
- No record
- Last trade
- 24/03/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AN2 TherapeuticsANTX | Open-market sale10b5-1 plan | 24/01/09 | 24/01/11 | 7,417 sh | $20.14 | $149,378.38 | −79.5% |
AN2 TherapeuticsANTX | Open-market sale10b5-1 plan | 24/01/02 | 24/01/04 | 2,583 sh | $20.12 | $51,969.96 | −57.4% |